FY2026 Annual Report, creditor update and Board changes

Sep 30, 2026 at 8:16 PM EDT · Issued by Chimeric Therapeutics Limited via ASX

Filed with ASX · Sep 30, 2026 at 8:16 PM EDT

On 6ix: 6ix.com/news/fy2026-annual-report-creditor-update-and-board-changes

Chimeric Therapeutics Limited ABN 68 638 835 828 www.chimerictherapeutics.com Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3025 AUSTRALIA ASX ANNOUNCEMENT 1 October 2026 FY2026 Annual Report, creditor update and Board changes Sydney, Australia, 1 October...

View Attachment

6ix hasn’t read this filing yet.

Chimeric Therapeutics Limited on 6ix

Story so far

Appendix 4E and Annual ReportAug 29, 2025

Earlier from Chimeric Therapeutics

Application for quotation of securities - CHMSep 29
Appendix 4E and Preliminary Final ReportAug 31
CHM ceases enrolment in Phase 1 trial and Company updateAug 18
Trading HaltAug 16
Quarterly Activities/Appendix 4C Cash Flow ReportJul 31

Later from Chimeric Therapeutics

Initial Director's Interest Notice - RMOct 5
Final Director's Interest Notice - BGOct 5
Final Director's Interest Notice - LROct 5
Notice of initial substantial holder for CHMOct 6
Ceasing to be a substantial holder for CHMOct 8

All Chimeric Therapeutics news releases

Follow Chimeric Therapeutics into a list and get an email when it puts out news.

Follow Chimeric Therapeutics